Search Results - "NAJEM, Abeer"

Effect of medical staff training on vaccination coverage in outpatients with cancer: An interventional multicenter before-and-after study by Rivière, Pierre, Penel, Nicolas, Faure, Karine, Marie, Guillaume, Najem, Abeer, Rivière, Marie-Karelle, Panaget, Sophie

“…Despite widely disseminated guidelines, pneumococcal and influenza vaccination coverage (VC) remains insufficient in patients with cancer receiving cancer…”
Get full text

Staphylococcus aureus mediastinitis due to subclavian vein perforation and catheter-related-infection by Rivière, Pierre, Bauer, Jules, Hégo, Florent, Raad, Naji, Najem, Abeer, Tomaszewski, Aurélie, Dandoy, Simon, Marie, Guillaume

“…•Very rare cause of acute infectious mediastinitis.•Second description in the literature and the first in an oncologic patient.•Treatment via adapted and…”
Get full text

Secondary Hemophagocytic Lymphohistiocytosis Following Dostarlimab Treatment in a Patient With Metastatic Endometrial Cancer by Rollet, Emilie, Puigrenier, Sebastien, Najem, Abeer, Desgrousilliers, Benoit, Riviere, Pierre

“…Immunotherapy is a rapidly expanding cancer treatment strategy. Dostarlimab is administered as the first-line treatment for metastatic endometrial cancer in…”
Get full text

Intertrigo-like dermatitis with pegylated liposomal doxorubicin: diagnosis and management by Najem, Abeer, Deregnaucourt, Delphine, Ramdane, Soraya, Dridba, Mohammed, Djouba, Felix, Vercambre-Darras, Sophie

Get full text

Abstract P4-01-20: Phase IV study evaluating talazoparib in patients with locally advanced or metastatic negative HER2 breast cancer and a somatic or germline BRCA1/2 mutation (ViTAL) – Analysis of cohort 1 according to hormonal receptor status by Loirat, Delphine, de la barre, Marie Duboys, Thery, Jean-Christophe, Hrab, Ioana, Jouannaud, Christelle, Mouysset, Jean-Loup, Salabert, Laura, Soibinet, Pauline, Mailliez, Audrey, Valery, Romain, Creisson, Anne, Villanueva, Cristian, Dohollou, Nadine, Fumet, Jean-david, grellety, Thomas, Perez-staub, Nathalie, Lachaier, Emma, Iltis-roux, Aurore, delbado, Miguel, Najem, Abeer, Scodan, Romuald Le, Curtit, Elsa, aldabbagh, kais, Pujol, Pascal, DE LA MOTTE ROUGE, thibault

“…Background: Talazoparib (TALA) is a highly potent, dual-mechanism PARP inhibitor that has demonstrated clinical benefit in EMBRACA Phase III trial for patients…”
Get full text

Staphylococcus aureus mediastinitis due to subclavian vein perforation and catheter-related-infection by Rivière, Pierre, Bauer, Jules, Hégo, Florent, Raad, Naji, Najem, Abeer, Tomaszewski, Aurélie, Dandoy, Simon, Marie, Guillaume

Get full text